Periostin action in bone

Molecular and Cellular Endocrinology

Volumn 432, Issue , 2016, Pages 75-82

  Bonnet, Nicolas ^a   Garnero, Patrick ^a   Ferrari, Serge ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biomarker; Bone; Exercise; Fracture; Periostin; PTH

Indexed keywords

BETA CATENIN; INTEGRIN RECEPTOR; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN; BIOLOGICAL MARKER; CELL ADHESION MOLECULE;

ARTICLE; ASTHMA; BIOMECHANICS; BONE CANCER; BONE CELL; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BONE MATRIX; BONE METABOLISM; BONE STRESS; BONE STRUCTURE; BONE TISSUE; CELL FUNCTION; CELL STIMULATION; CORTICAL BONE; DRUG INTERMITTENT THERAPY; FRACTURE; FRACTURE HEALING; HEART INFARCTION; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; MECHANICAL STRESS; METASTASIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERIOSTEUM; PHENOTYPE; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TOOTH DEVELOPMENT; TRANSCRIPTION FACTOR RUNX2 BLOOD LEVEL; TREATMENT RESPONSE; ANIMAL; BONE; CHEMISTRY; DRUG EFFECTS; METABOLISM;

ANIMALS; BIOMARKERS; BIOMECHANICAL PHENOMENA; BONE AND BONES; CELL ADHESION MOLECULES; FRACTURE HEALING; HUMANS; PARATHYROID HORMONE; SIGNAL TRANSDUCTION;

EID: 84953455391     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.12.014     Document Type: Article

References (63)

1. Anastasilakis, A.D., Polyzos, S.A., Makras, P., Savvides, M., Sakellariou, G.T., Gkiomisi, A., et al. Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment. Horm. Metab. Res. 46 (2014), 145–149.
2. Baron, R., Kneissel, M., WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19:2 (2013), 179–192.
3. Bianchi, E.N., Ferrari, S.L., Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts. Bone 45:4 (2009), 716–725.
4. Bonewald, L.F., The amazing osteocyte. J. Bone Min. Res. 26:2 (2011), 229–238.
5. Bonnet, N., Ferrari, S., Periostin (Postn) synergizes with osteocytes beta-catenin to mediate the adaptive skeletal response to loading Bone. ECTS Meeting, 2013, 47.
6. Bonnet, N., Ferrari, S., Periostin prevents cortical bone loss by increasing OPG levels in response to continuous PTH in mice. J. Bone Min. Res., 2015, s24.
7. Bonnet, N., Standley, K.N., Bianchi, E.N., Stadelmann, V., Foti, M., Conway, S.J., et al. The matricellular protein Periostin is required for Sclerostin inhibition and the anabolic response to mechanical loading and physical activity. J. Biol. Chem. 284:51 (2009), 35939–35950.
8. Bonnet, N., Conway, S.J., Ferrari, S.L., Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc. Natl. Acad. Sci. U. S. A. 109:37 (2012), 15048–15053.
9. Bonnet, N., Lesclous, P., Saffar, J.L., Ferrari, S., Zoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient mice. PLoS One, 8(3), 2013, e58726.
10. Bonnet, N., Gineyts, E., Ammann, P., Conway, S.J., Garnero, P., Ferrari, S., Periostin deficiency increases bone damage and impairs injury response to fatigue loading in adult mice. PLoS One, 8(10), 2013, e78347.
11. Bonnet, N., Biver, E., Durosier, C., Chevalley, T., Rizzoli, R., Ferrari, S., Additive genetic effects on circulating periostin contribute to the heritability of bone microstructure. J. Clin. Endocrinol. Metab. 100:7 (2015), E1014–E1021.
12. Chan, C.S.L., Leung, C.M., Chan, D., Cheah, K.S.E., Tanner, J.A., Periostin interacts with sclerostin and inhibits its antagonistic effect on Wnt signalling. International Bone and Mineral Workshops, 2008 Switzerland March 9–11:Davos.
13. Coutu, D.L., Wu, J.H., Monette, A., Rivard, G.E., Blostein, M.D., Galipeau, J., Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J. Biol. Chem. 283:26 (2008), 17991–18001.
14. Duong le, T., Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation. Bonekey Rep., 2(1), 2012, 67.
15. Fortunati, D., Reppe, S., Fjeldheim, A.K., Nielsen, M., Gautvik, V.T., Gautvik, K.M., Periostin is a collagen associated bone matrix protein regulated by parathyroid hormone. Matrix Biol. 29:7 (2010), 594–601.
16. Gerbaix, M., Vico, L., Ferrari, S.L., Bonnet, N., Periostin expression contributes to cortical bone loss during unloading. Bone 71 (2015), 94–100.
17. Gerbaix, M., Vico, L., Ferrari, S.L., Bonnet, N., Periostin expression contributes to cortical bone loss during unloading. Bone 71 (2015), 94–100.
18. Ghatak, S., Misra, S., Norris, R.A., Moreno-Rodriguez, R.A., Hoffman, S., Levine, R.A., et al. Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J. Biol. Chem. 289:12 (2014), 8545–8561.
19. Gillan, L., Matei, D., Fishman, D.A., Gerbin, C.S., Karlan, B.Y., Chang, D.D., Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62:18 (2002), 5358–5364.
20. Haertel-Wiesmann, M., Liang, Y., Fantl, W.J., Williams, L.T., Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J. Biol. Chem. 275:41 (2000), 32046–32051.
21. Heo, S.C., Shin, W.C., Lee, M.J., Kim, B.R., Jang, I.H., Choi, E.J., et al. Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold. PLoS One, 10(3), 2015, e0116698.
22. Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H., Katsuura, M., Ozawa, H., et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Min. Res. 14:7 (1999), 1239–1249.
23. Kii, I., Amizuka, N., Minqi, L., Kitajima, S., Saga, Y., Kudo, A., Periostin is an extracellular matrix protein required for eruption of incisors in mice. Biochem. Biophys. Res. Commun. 342:3 (2006), 766–772.
24. Kim, B.J., Rhee, Y., Kim, C.H., Baek, K.H., Min, Y.K., Kim, D.Y., et al. Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: clinical evidence for the different effects of periostin depending on the skeletal site. Bone 81 (2015), 435–441.
25. Kramer, I., Halleux, C., Keller, H., Pegurri, M., Gooi, J.H., Weber, P.B., et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol. Cell. Biol. 30:12 (2010), 3071–3085.
26. Kramer, I., Keller, H., Leupin, O., Kneissel, M., Does osteocytic SOST suppression mediate PTH bone anabolism?. Trends Endocrinol. Metab. 21:4 (2010), 237–244.
27. Kudo, A., Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell. Mol. Life Sci. 68:19 (2011), 3201–3207.
28. Kühn, B., del Monte, F., Hajjar, R.J., Chang, Y.S., Lebeche, D., Arab, S., et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 13:8 (2007), 962–969.
29. Li, X., Liu, H., Qin, L., Tamasi, J., Bergenstock, M., Shapses, S., et al. Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J. Biol. Chem. 282:45 (2007), 33086–33097.
30. Litvin, J., Selim, A.H., Montgomery, M.O., Lehmann, K., Rico, M.C., Devlin, H., et al. Expression and function of periostin-isoforms in bone. J. Cell. Biochem. 92:5 (2004), 1044–1061.
31. Lotinun, S., Kiviranta, R., Matsubara, T., Alzate, J.A., Neff, L., Lüth, A., et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Invest. 123:2 (2013), 666–681.
32. Lv, J., Sun, X., Ma, J., Ma, X., Xing, G., Wang, Y., et al. Involvement of periostin-sclerostin-Wnt/β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin. Biochem. Biophys. Res. Commun. 468:4 (2015), 587–593.
33. Masuoka, M., Shiraishi, H., Ohta, S., Suzuki, S., Arima, K., Aoki, S., et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J. Clin. Invest. 122:7 (2012), 2590–2600.
34. Merle, B., Garnero, P., The multiple facets of periostin in bone metabolism. Osteoporos. Int. 23:4 (2012), 1199–1212.
35. Merle, B., Bouet, G., Rousseau, J.C., Bertholon, C., Garnero, P., Periostin and transforming growth factor β-induced protein (TGFβIp) are both expressed by osteoblasts and osteoclasts. Cell Biol. Int. 38:3 (2014), 398–404.
36. Mohan, S., Wergedal, J.E., Das, S., Kesavan, C., Conditional disruption of miR17-92 cluster in collagen type I-producing osteoblasts results in reduced periosteal bone formation and bone anabolic response to exercise. Physiol. Genom. 47:2 (2015), 33–43.
37. Morra, L., Moch, H., Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 459:5 (2011), 465–475.
38. Morra, L., Rechsteiner, M., Casagrande, S., von Teichman, A., Schraml, P., Moch, H., et al. Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer 76:2 (2012), 183–190.
39. Movérare-Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Börjesson, A.E., et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat. Med. 20:11 (2014), 1279–1288.
40. Onyia, J.E., Helvering, L.M., Gelbert, L., Wei, T., Huang, S., Chen, P., et al. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J. Cell. Biochem. 95:2 (2005), 403–418.
41. Ozdemir, C., Akpulat, U., Sharafi, P., Yıldız, Y., Onbaşılar, I., Kocaefe, C., Periostin is temporally expressed as an extracellular matrix component in skeletal muscle regeneration and differentiation. Gene 553:2 (2014), 130–139.
42. Rani, S., Barbe, M.F., Barr, A.E., Litvin, J., Periostin-like-factor and Periostin in an animal model of work-related musculoskeletal disorder. Bone 44:3 (2009), 502–512.
43. Ren, Y., Han, X., Ho, S.P., Harris, S.E., Cao, Z., Economides, A.N., et al. Removal of SOST or blocking its product sclerostin rescues defects in the periodontitis mouse model. FASEB J. 2:7 (2015), 2702–2711.
44. Reppe, S., Stilgren, L., Olstad, O.K., Brixen, K., Nissen-Meyer, L.S., Gautvik, K.M., et al. Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone 39:1 (2006), 189–198.
45. Rios, H., Koushik, S.V., Wang, H., Wang, J., Zhou, H.M., Lindsley, A., et al. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 25:24 (2005), 11131–11144.
46. Robling, A.G., Kedlaya, R., Ellis, S.N., Childress, P.J., Bidwell, J.P., Bellido, T., et al. Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice. Endocrinology 152:8 (2011), 2963–2975.
47. Rosselli-Murai, L.K., Almeida, L.O., Zagni, C., Galindo-Moreno, P., Padial-Molina, M., Volk, S.L., et al. Periostin responds to mechanical stress and tension by activating the MTOR signaling pathway. PLoS One, 8(12), 2013, e83580.
48. Rousseau, J., Sornay-Rendu, E., Bertholon, C., Chapurlat, R., Garnero, P., Serum periostin is associated with fracture risk in postmenopausal women: a 7 years prospective analysis of the OFELY study. J. Clin. Endocrinol. Metab. 3893 (2014), 1–7.
49. Rousseau, J.C., Sornay-Rendu, E., Bertholon, C., Garnero, P., Chapurlat, R., Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study. Osteoarthr. Cartil. 23:10 (2015), 1736–1742.
50. Ruan, K., Bao, S., Ouyang, G., The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 66:14 (2009), 2219–2230.
51. Schaffler, M.B., Choi, K., Milgrom, C., Aging and matrix microdamage accumulation in human compact bone. Bone 17:6 (1995), 521–525.
52. Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., et al. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205:2 (2008), 295–303.
53. Takeshita, S., Kikuno, R., Tezuka, K., Amann, E., Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294 (1993), 271–278.
54. Thorfve, A., Bergstrand, A., Ekstrφm, K., Lindahl, A., Thomsen, P., Larsson, A., et al. Gene expression profiling of peri-implant healing of PLGA-Li+ implants suggests an activated Wnt signaling pathway in vivo. PLoS One, 9(7), 2014, e102597.
55. Tkatchenko, T.V., Moreno-Rodriguez, R.A., Conway, S.J., Molkentin, J.D., Markwald, R.R., Tkatchenko, A.V., Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol. Genom. 39:3 (2009), 160–168.
56. Uchida, M., Shiraishi, H., Ohta, S., Arima, K., Taniguchi, K., Suzuki, S., et al. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 46:5 (2012), 677–686.
57. Vico, L., Alexandre, C., Microgravity and bone adaptation at the tissue level. J. Bone Min. Res. 7:Suppl. 2 (1992), S445–S447.
58. Vico, L., Lafage-Proust, M.H., Alexandre, C., Effects of gravitational changes on the bone system in vitro and in vivo. Bone 22:5 Suppl. (1998), 95S–100S.
59. Wergedal, J.E., Kesavan, C., Brommage, R., Das, S., Mohan, S., Role of WNT16 in the regulation of periosteal bone formation in female mice. Endocrinology 156:3 (2015), 1023–1032.
60. Wilde, J., Yokozeki, M., Terai, K., Kudo, A., Moriyama, K., The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement. Cell Tissue Res. 312:3 (2003), 345–351.
61. Yamada, S., Tauchi, T., Awata, T., Maeda, K., Kajikawa, T., Yanagita, M., et al. Characterization of a novel periodontal ligament-specific periostin isoform. J. Dent. Res. 93:9 (2014), 891–897.
62. Zhang, Z., Nie, F., Chen, X., Qin, Z., Kang, C., Chen, B., et al. Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin-1. Mol. Med. Rep. 11:2 (2015), 857–864.
63. Zhu, S., Barbe, M.F., Liu, C., Hadjiargyrou, M., Popoff, S.N., Rani, S., et al. Periostin-like-factor in osteogenesis. J. Cell. Physiol. 218:3 (2009), 584–592.